Side-by-side comparison of AI visibility scores, market position, and capabilities
Hopper is the AI-powered travel booking app that predicts flight and hotel prices, serving 100M+ users with $850M revenue and $7.5B+ total bookings through its consumer app and B2B platform.
Hopper is a travel booking application that has grown into one of the most downloaded travel apps globally by combining AI-powered price prediction with a consumer-friendly mobile interface. Founded in 2007 and headquartered in Montreal, Hopper spent its first decade building a proprietary dataset of flight prices before launching its consumer app in 2015. The app's signature feature—predicting whether prices will rise or fall and recommending when to buy—resonated with cost-conscious travelers who wanted confidence that they were buying at the right time.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.